Showing 17,301 - 17,320 results of 46,043 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (mean decrease)) ))', query time: 1.11s Refine Results
  1. 17301

    Influence of Solubilizing Group Removal Rate on the Morphology and Crystallinity of a Diketopyrrolopyrrole-Based Compound by Shabi Thankaraj Salammal (1864396)

    Published 2014
    “…This means that, when the heating rate is decreased from 50 to 0.1 °C/min, the crystallinity of DPP-4T powder decreases from 49% to 34%, and the grain size of DPP-4T film reduces from 976 to 344 nm. …”
  2. 17302
  3. 17303
  4. 17304

    Data Sheet 1_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  5. 17305

    Data Sheet 2_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  6. 17306

    Data Sheet 3_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  7. 17307

    Data Sheet 4_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  8. 17308

    Spread of a DENV mutant with defective 2’-O-methylation of the viral RNA genome. by Bianca Schmid (555102)

    Published 2015
    “…A549-IFIT1deGFP cells were infected with the DENV-faR E217A mutant at a MOI of 0.1 TCID<sub>50</sub>/cell. …”
  9. 17309
  10. 17310

    Electrochemistry as a Complementary Technique for Revealing the Influence of Reducing Agent Concentration on AgNPs. by Sapokazi Timakwe (14127576)

    Published 2023
    “…This process ended up in the formation of large aggregates that decrease the active surface area and therefore result in a significant decrease in their unique properties. …”
  11. 17311
  12. 17312

    Titration of K<sup>+</sup> currents by TMA and TEA. by Radhakrishnan Gnanasambandam (2213545)

    Published 2015
    “…The junction potentials were ignored (for mixed solutions of TMA and TEA) because they were between -0.5mV and -3.7 mV for 20–150 mM TMA; for 20–150 mM TEA they were between -0.7 mV and -5.3 mV. …”
  13. 17313

    RECQL4 functions in a separate pathway from REV1 and is degraded following DNA crosslinks. by Thong T. Luong (13833935)

    Published 2022
    “…<p>(A) RECQL4 levels decrease following cisplatin treatment. …”
  14. 17314

    Orchio-Septopexy: A new technique to cover and fix detorsed testis undergoing fasciotomy of tunica albuginea by Mohammed Elifranji (13160309)

    Published 2022
    “…Results Orchio-septopexy was performed in 11 cases with a mean age of 11.9 years (3-17). All cases had clinic follow-up and testicular Doppler US with a mean of 9.5 months (6-24). 6/11 cases (54%) were salvaged, with good vascularity in the Doppler US and maintained more than 50% testicular volume compared to the contralateral side. …”
  15. 17315
  16. 17316

    Table_1_Giant cell temporal arteritis: a clinicopathological study with emphasis on unnecessary biopsy.pdf by Hind M. Alkatan (11592654)

    Published 2023
    “…In the group with positive TA biopsies, the mean age was 71 ± 8.4 years with a higher female predominance (female-to-male ratio of 5:3). …”
  17. 17317

    Data_Sheet_1_Estimation of the economic impact of a bluetongue serotype 4 outbreak in Tunisia.docx by Ameni Ben Salem (18073126)

    Published 2024
    “…In cattle, exposure to BTV led to a daily unit milk yield decrease of 12.50 to 14.66 L over an average period of 5 months. …”
  18. 17318
  19. 17319

    Retinal morphology and function is damaged in TALEN <i>clcc1</i>-KO zebrafish. by Lin Li (28817)

    Published 2018
    “…ON bipolar cell spectral sensitivity is depressed over 50% in mutants. Sensitivity axis is in units of nV per quantum as calculated from the amplitude of responses to constant quanta stimulation across the spectrum (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1007504#pgen.1007504.e001" target="_blank">Eq 1</a>). …”
  20. 17320

    Blockade of Alk receptor activation abolishes neuronal differentiation due to Activin A treatment. by Griselda Rodríguez-Martínez (140821)

    Published 2012
    “…Addition of growth factors and inhibitors was made every other day. SB431542 (Alk4, Alk5 and Alk7 inhibitor, 5 µM), Follistatin (Activin A ligand-trap, 20 ng/ml) or Dorsomorphin (BMP antagonists, 5 µM) were added to NPC cultures 1 hour previous to Activin A. …”